全文获取类型
收费全文 | 48589篇 |
免费 | 2705篇 |
国内免费 | 124篇 |
专业分类
耳鼻咽喉 | 667篇 |
儿科学 | 1744篇 |
妇产科学 | 755篇 |
基础医学 | 6269篇 |
口腔科学 | 1090篇 |
临床医学 | 3453篇 |
内科学 | 12211篇 |
皮肤病学 | 1435篇 |
神经病学 | 4058篇 |
特种医学 | 1305篇 |
外科学 | 7071篇 |
综合类 | 269篇 |
一般理论 | 16篇 |
预防医学 | 4050篇 |
眼科学 | 1211篇 |
药学 | 2917篇 |
中国医学 | 189篇 |
肿瘤学 | 2708篇 |
出版年
2024年 | 48篇 |
2023年 | 358篇 |
2022年 | 338篇 |
2021年 | 1320篇 |
2020年 | 626篇 |
2019年 | 1449篇 |
2018年 | 2249篇 |
2017年 | 1318篇 |
2016年 | 1127篇 |
2015年 | 1058篇 |
2014年 | 1309篇 |
2013年 | 2161篇 |
2012年 | 3747篇 |
2011年 | 4191篇 |
2010年 | 2012篇 |
2009年 | 1251篇 |
2008年 | 3198篇 |
2007年 | 3316篇 |
2006年 | 2966篇 |
2005年 | 3080篇 |
2004年 | 2847篇 |
2003年 | 2699篇 |
2002年 | 2487篇 |
2001年 | 1454篇 |
2000年 | 1879篇 |
1999年 | 994篇 |
1998年 | 302篇 |
1997年 | 179篇 |
1996年 | 176篇 |
1995年 | 148篇 |
1994年 | 106篇 |
1993年 | 108篇 |
1992年 | 110篇 |
1991年 | 86篇 |
1990年 | 56篇 |
1989年 | 60篇 |
1988年 | 64篇 |
1987年 | 40篇 |
1986年 | 52篇 |
1985年 | 56篇 |
1984年 | 53篇 |
1983年 | 47篇 |
1982年 | 38篇 |
1981年 | 30篇 |
1980年 | 32篇 |
1978年 | 24篇 |
1977年 | 16篇 |
1976年 | 17篇 |
1975年 | 21篇 |
1973年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Cromb Amandine Le Loarer Franois Sitbon Maxime Italiano Antoine Stoeckle Eberhard Buy Xavier Kind Michle 《European radiology》2020,30(5):2413-2424
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification... 相似文献
5.
6.
Selwyn Arlington Headley Nayara Emily Viana Mariana de Mello Zanim Michelazzo Ana Aparecida Correa Xavier Cícero Júlio Silva Costa Felipe Hideki Ogo de Pinho Marcelo Diniz dos Santos 《Transboundary and Emerging Diseases》2020,67(Z2):49-59
Neorickettsia helminthoeca (NH), the agent of salmon poisoning disease or canine neorickettiosis (CN), is a bacterial endosymbiont of the nematode Nanophyetus salmincola, and infections are spreading among specific fish‐eating mammalians. This article describes the pathologic and immunohistochemical findings associated with spontaneous NH‐induced infections in dogs from Southern Brazil. The principal pathologic findings were hypertrophy of Peyer patches and lymphadenopathy with lymphocytic proliferation, chronic interstitial pneumonia, and chronic enteritis associated with positive intralesional immunoreactivity to antigens of NH within macrophages and histiocytes. Positive immunoreactivity against canine parvovirus‐2 (CPV‐2) or/and canine distemper virus was not detected in the evaluated intestinal segments or in the samples from the cerebellum and lungs, respectively, from the dogs evaluated. These findings demonstrated that NH was involved in the enteric, pulmonary, and lymphoid lesions herein described, and provide additional information to confirm the occurrence of this bacterial endosymbiont within this geographical location. It is proposed that chronic pneumonia should be considered as a pathologic manifestation of NH‐induced infections. Additionally, our results show that the occurrences of CN seem to be underdiagnosed in Southern Brazil due to the confusion with the incidence of CPV‐2. 相似文献
7.
8.
9.
10.
Pierre Tiberghien Xavier de Lamballerie Pascal Morel Pierre Gallian Karine Lacombe Yazdan Yazdanpanah 《Vox sanguinis》2020,115(6):488-494
Plasma provided by COVID-19 convalescent patients may provide therapeutic relief as the number of COVID-19 cases escalates steeply worldwide. Prior findings in various viral respiratory diseases including SARS-CoV-related pneumonia suggest that convalescent plasma can reduce mortality, although formal proof of efficacy is still lacking. By reducing viral spread early on, such an approach may possibly downplay subsequent immunopathology. Identifying, collecting, qualifying and preparing plasma from convalescent patients with adequate SARS-CoV-2-neutralizing Ab titres in an acute crisis setting may be challenging, although well within the remit of most blood establishments. Careful clinical evaluation should allow to quickly establish whether such passive immunotherapy, administered at early phases of the disease in patients at high risk of deleterious evolution, may reduce the frequency of patient deterioration, and thereby COVID-19 mortality. 相似文献